Your Messages Inbox
Most Viewed Abstracts
1. Report Shows Shift in Starting Salaries for Physicians 2. 2008 Exclusive Survey—Earnings: Good news for primary care income 3. Medicare pay-for-reporting effort draws fire from frustrated doctors 4. Debunking Myths in the US Healthcare System 5. Doctors and the DEA Free full text
Top Ten Searches
parkinson's neuritis neuralgia myasthenia gravis lactic acidosis ataxia seizure tinnitus migraine hypotoniaYour Article Summary
See Latest ArticlesThe Toll of Opioid-Induced Glial Activation: Improving the Clinical Efficacy of Opioids by Targeting Glia
Trends in Pharmacological Sciences, 09/18/09
Watkins LR et al. – Glial activation participates in the mediation of pain including neuropathic pain, due to release of neuroexcitatory, proinflammatory products. Glial activation is now known to occur in response to opioids as well. Opioid–induced glial activation opposes opioid analgesia and enhances opioid tolerance, dependence, reward and respiratory depression. Such effects can occur, not via classical opioid receptors, but rather via non–stereoselective activation of toll–like receptor 4, a recently recognized key glial receptor participating in neuropathic pain as well.
Related Articles
Systemic opioid and chronic pain
European Journal of Pain, 11/12/09
Relevance Score: 69%
Synthesis and pharmacological properties of a new fluorescent opioid peptide analog
Pharmacological Reports, 10/12/09
Relevance Score: 69%
The Effects of Opioids and Opioid Analogs on Animal and Human Endocrine Systems
Endocrine Reviews, 11/11/09
Relevance Score: 68%
Morphine/naltrexone extended-release capsules (Embeda): Combination of mu-opioid agonist and mu-opioid antagonist approved for the management of moderate-to-severe pain when continuous analgesia is needed for an extended time period
Formulary, 11/02/09
Relevance Score: 68%
Comparison of the Anti-nociceptive and Anti-Rewarding Profiles of Novel Bifunctional Nociceptin/Orphanin FQ Receptor (NOPr)-Mu Opioid Receptor (MOPr) Ligands: Implications for Therapeutic Applications
Journal of Pharmacology and Experimental Therapeutics, 10/07/09
Relevance Score: 68%
Today in Neuro/Psych pharmacology...keeping you current
Receive free subspecialty "5-minute updates" via email
Progesterone treatment for brain injury: an update
Future Neurology, 12/20/09
Cancer informatics for the clinician: An interaction database for chemotherapy regimens and antiepileptic drugs
Seizure - European Journal of Epilepsy, 12/20/09
Probable levetiracetam-associated depression in the elderly: Two case reports
The American Journal of Geriatric Pharmacotherapy, 12/18/09
Sponsor
Article Search
Sponsor
Sponsor